Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
6.69
+0.50 (8.08%)
At close: Feb 6, 2026, 4:00 PM EST
6.68
-0.01 (-0.15%)
After-hours: Feb 6, 2026, 7:05 PM EST

Unicycive Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
42.726.149.70.4616.58-
Cash & Short-Term Investments
42.726.149.70.4616.58-
Cash Growth
31.99%169.48%2032.09%-97.26%--
Prepaid Expenses
6.713.873.372.031.71-
Other Current Assets
0.880.940.330.160.130.2
Total Current Assets
50.2930.9513.42.6418.410.2
Property, Plant & Equipment
0.320.720.790.170.33-
Total Assets
50.6131.6714.192.8218.740.2
Accounts Payable
0.961.060.840.890.740.18
Accrued Expenses
2.763.563.232.241.210.18
Short-Term Debt
-----2.51
Current Portion of Leases
0.270.560.330.160.15-
Other Current Liabilities
9.1518.9413.13---
Total Current Liabilities
13.1324.1217.533.282.112.88
Long-Term Leases
-0.120.47-0.16-
Total Liabilities
13.1324.24183.282.262.88
Common Stock
0.020.110.040.020.020.01
Additional Paid-In Capital
150.62108.5960.733.5232.413.24
Retained Earnings
-113.16-101.27-64.54-34-15.94-5.92
Shareholders' Equity
37.487.43-3.81-0.4716.48-2.67
Total Liabilities & Equity
50.6131.6714.192.8218.740.2
Total Debt
0.270.680.790.160.312.51
Net Cash (Debt)
42.4325.468.910.316.27-2.51
Net Cash Growth
34.53%185.82%2869.33%-98.16%--
Net Cash Per Share
3.223.803.630.2013.94-2.96
Filing Date Shares Outstanding
21.4911.973.481.521.50.89
Total Common Shares Outstanding
20.8511.383.481.521.50.85
Working Capital
37.166.83-4.14-0.6416.31-2.67
Book Value Per Share
1.800.65-1.10-0.3110.99-3.14
Tangible Book Value
37.487.43-3.81-0.4716.48-2.67
Tangible Book Value Per Share
1.800.65-1.10-0.3110.99-3.14
Machinery
0.070.060.020.010.01-
Construction In Progress
-0.01----
Leasehold Improvements
0.070.050.020.020.02-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q